CGRP receptor drugs for Migraine
5 tracked CGRP receptor drugs in the Migraine race. The class explanation lives on the CGRP receptor page; the full indication pipeline across every mechanism is on the Migraine page.
5 approved / phase 4
Head-to-head evidence: Atogepant (Qulipta) vs Erenumab (Aimovig) · Atogepant (Qulipta) vs Rimegepant (Nurtec ODT) · Atogepant (Qulipta) vs Ubrogepant (Ubrelvy) · Atogepant (Qulipta) vs Zavegepant (Zavzpret) · Erenumab (Aimovig) vs Rimegepant (Nurtec ODT) · Erenumab (Aimovig) vs Ubrogepant (Ubrelvy)